• Denmark

20092019
If you made any changes in Pure these will be visible here soon.

Personal profile

Curriculum

Positions held
since January 2009 Full professor (chair) of pharmacy (professor i lægemiddelvidenskab) at Dept. Chemistry and Physics, University of Southern Denmark, Odense, Denmark
01/2009 to 12/2010 adjunct professor (professor II) at Dept. Pharmaceutics & Biopharma-ceutics, Institute of Pharmacy, University of Tromsø (UiT), Tromsø, Norway
04/1998 to 12/2008 Full professor (chair) in pharmaceutics (professor i legemiddelteknologi) at Dept. of Pharmaceutics & Biopharmaceutics, Inst. Pharmacy, Tromsø, Norway
02/1992 to 03/1998 assistant professor (adjunkt) in pharmaceutics, Institute of Pharmacy, Department of Pharmaceutical Technology, Albert-Ludwigs-University (ALU) Freiburg, Germany
02/1991 to 02/1992 Postdoctoral fellow, personal grant Deutsche Forschungsgemeinschaft Bonn, Germany
08/1987 to 02/1991 Head of department of pharmaceutical affairs and registration (part time), GRY Pharma GmbH, Kirchzarten, Germany, (medium-sized pharmaceutical company)
01/1986 to 08/1987 Scientific officer at department of pharmaceutical affairs and registration (part time), GRY Pharma GmbH, Kirchzarten, Germany

Degrees earned
May 1998 Dr. habil. and venia legendi in pharmaceutics (Pharmazeutische Technologie) Faculty of Chemistry and Pharmacy, ALU Freiburg, Germany
July 1990 Dr. rer. nat. in pharmaceutics „summa cum laude“, Faculty of Chemistry and Pharmacy, ALU Freiburg, Germany, supervisor Prof. Dr. K.H. Bauer
Dec. 1985 „Approbation als Apotheker“ (equivalent to master of pharmacy / cand. pharm.), Bayerisches Staatsministerium des Inneren, Munich, Germany

Foreign research periods
2008 Guest professor at Inst. Pharmacy, ALU Freiburg, Germany, Prof. Dr. R. Schubert
2006 Guest professor at Tumor Biology Center, Freiburg, Germany, Prof. Dr. C. Unger 
2003 Guest professor at Tumor Biology Center, Freiburg, Germany, Prof. Dr. C. Unger
1995 Guest researcher at Dept. Pharmaceutics, Univ. Kuopio, Finland, Prof. Dr. P. Paronen,
1993 Guest researcher at Centre for Drug Delivery Research, School of Pharmacy, Univ. London, U.K., Prof. Dr. G. Gregoriadis
02/1991 to 02/1992 Postdoctoral researcher at Centre for Drug Delivery Research (CDDR), School of Pharmacy, University of London, U.K., Prof. Dr. G. Gregoriadis

Administrative and managenment experience
At SDU
since 08/2010 leader for pharmacy study program and head of program committee

At University of Tromsø
1998 – 2000 & 2005 - 2006 Head of Dept. Pharmaceutics & Biopharmaceutics, Inst. Pharmacy (IFA)
2001 - 2004 Leader of research center “Drug Transport & Drug Delivery”
1998 - 2000 & 2002 –2005 Member of institute board (instituttstyret), IFA
2004 - 2006 Member of teaching committee (undervisningsutvalget) at Medical Faculty
2000 - 2001 Member of Research Committee (forskningsutvalget) at Medical Faculty

Supervision
main supervisor of 8 PhDs (defended) and 4 ongoing phD-students, co-supervisor of 4 ongoing PhD-students
main supervisor of 2 former and 2 ongoing postdoctoral fellows

 

 

Keywords

  • Pharmaceuticals
  • Drug delivery from nanoparticles
  • Nanotechnology
  • Processing of animal and vegetable raw materials for food, feed and pharmaceuticals
  • Development of new drugs
  • Chromatography
  • Lipidomics
  • Cancer
  • Caractirisation and manipulation of nano structures
  • Drug delivery from nanoparticles
  • Nanomaterials
  • Nanotechnology
  • Cancer
  • Pharmaceuticals
  • Development of new drugs
  • Particles, cores
  • Nanotechnology and nanoscience
  • Nanomedicine

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Celecoxib Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Field Flow Fractionation Medicine & Life Sciences
Phospholipids Medicine & Life Sciences
Lipids Medicine & Life Sciences
Microdialysis Medicine & Life Sciences
Micelles Medicine & Life Sciences
Membranes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

A dynamic in vitro permeation study on solid mono- and diacyl-phospholipid dispersions of celecoxib

Jacobsen, A-C., Elvang, P. A., Bauer-Brandl, A. & Brandl, M., Jan 2019, In : European Journal of Pharmaceutical Sciences. 127, p. 199-207

Research output: Contribution to journalJournal articleResearchpeer-review

Celecoxib
Phospholipids
Micelles
In Vitro Techniques
Field Flow Fractionation
Celecoxib
Phospholipids
Pharmaceutical Preparations
Field Flow Fractionation
tert-Butyl Alcohol

Drug permeability profiling using cell-free permeation tools: Overview and applications

Berben, P., Bauer-Brandl, A., Brandl, M., Faller, B., Flaten, G. E., Jacobsen, A-C., Brouwers, J. & Augustijns, P., 2018, In : European Journal of Pharmaceutical Sciences. 119, p. 219-233

Research output: Contribution to journalReviewResearchpeer-review

Cell-Free System
Pharmaceutical Preparations
Membranes
Excipients
Phospholipids

Oromucosal drug delivery: Trends in in-vitro biopharmaceutical assessment of new chemical entities and formulations

Brandl, M. & Bauer-Brandl, A., Nov 2018, In : European Journal of Pharmaceutical Sciences. 128, 1, p. 112-117

Research output: Contribution to journalJournal articleResearchpeer-review

Pharmaceutical Preparations
Drug Compounding
Cheek
Phospholipids
Membranes

PermeaLoop™, a novel in vitro tool for small-scale drug-dissolution/permeation studies

Sironi, D., Rosenberg, J., Bauer-Brandl, A. & Brandl, M., 2018, In : Journal of Pharmaceutical and Biomedical Analysis. 156, 15 July, p. 247-251

Research output: Contribution to journalJournal articleResearchpeer-review

N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
Permeation
Dissolution
Pharmaceutical Preparations
Tablets

Activities 2016 2018

  • 14 Talks and presentations in private or public companies
  • 6 Conference presentations

Neue in vitro Methoden zur Vorhersage der oralen Bioverfügbarkeit von Arzneimitteln mit schlecht wasserlöslichen Arzneistoffen

Martin Brandl (Guest lecturer)
6 Mar 2018

Activity: Talks and presentationsTalks and presentations in private or public companies

In vitro permeation / absorption: the basics

Martin Brandl (Guest lecturer)
24 Oct 2018

Activity: Talks and presentationsTalks and presentations in private or public companies

Promoting the mechanistic understanding of enabling oral formulations: what can in-vitro tools contribute?

Martin Brandl (Guest lecturer)
6 Dec 2018

Activity: Talks and presentationsTalks and presentations in private or public companies

Colloidal structures and drug absorption: from amorphous nanoparticles to bile salt micelles

Martin Brandl (Guest lecturer)
24 May 2018

Activity: Talks and presentationsConference presentations

Prediction of bioavailability

Martin Brandl (Guest lecturer)
24 Oct 2018

Activity: Talks and presentationsTalks and presentations in private or public companies

Projects 2014 2019

Prizes

Multi-angle light scattering detector for existing Asymmetrical Flow Field-Flow Fractionation (AF4) instrument

Martin Brandl (Recipient), Koji Kinoshita (Recipient), Changzhu Wu (Recipient), Judith Kuntsche (Recipient), Paul C. Stein (Recipient), Stefan Vogel (Recipient), Annette Bauer-Brandl (Recipient), Daniel Bar-Shalom (Recipient), Jette Jacobsen (Recipient) & Camilla Foged (Recipient), 21 Nov 2018

Prize: Prizes, scholarships, distinctions